Richard Bleicher, MD, FACS

Richard Bleicher, MD, FACS
(4.8/5.0)
116 Patient Satisfaction Ratings
Request an Appointment

Clinical Locations

Professor, Department of Surgical Oncology

Attending Surgeon

Leader, Breast Cancer Program

Director, Breast Fellowship Program

Specialties

Treatment Focus

Novel Treatment Modalities for Breast Cancer, Breast Cancer Clinical Trials, Cosmetic Outcomes in the Treatment of Breast Cancer 

Research Program

Key Awards

Philadelphia Magazine Top Docs 2022
Surgery

Jamie Brooke Lieberman Remembrance Award, Susan G. Komen® Philadelphia, 2020

Appointments

  • Member, Board of Directors, American College of Surgeons National Accreditation Program for Breast Centers
  • Chairman, Quality Improvement and Informaton Technology Committee, American College of Surgeons National Accreditation Program for Breast Centers
  • Surveyor, American College of Surgeons National Accreditation Program for Breast Centers
  • Vice Chairman, Society of Surgical Oncology Breast Fellowship Program Directors Training Committee
  • Committee Member, Commission on Cancer Operative Standards Committee
  • Committee Member, Commission on Cancer, Quality Integration Committee

Treatment Philosophy

I am acutely aware of the impact that a breast cancer diagnosis has on an individual. I do my best to foster a positive environment in which to start my patients' course of treatment and take the time to explain the pros and cons of each treatment option, so that they can make an informed decision. My treatment philosophy also includes, not just an emphasis on successful treatment, but also preserving a good cosmetic outcome. I feel fortunate to be a fellowship trained, very highly specialized clinician practicing at Fox Chase Cancer Center, which is an NCI-Designated Comprehensive Cancer Center, because this combination of factors allows me, and our treatment team, to focus on one thing all day, every day, and do it well: curing breast cancer. I think there is nothing more rewarding that I could do as a clinician. 

Follow on Twitter: @RichardBleicher 

Educational Background

  • Fellow, Basic Science Research, Mercy Hospital of Pittsburgh, Pittsburgh, PA
  • Fellow, Surgical Oncology, John Wayne Cancer Institute, Santa Monica, CA
  • Resident, Mercy Hospital of Pittsburgh, Pittsburgh, PA
  • MD, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, 1994
  • BA, University of Pennsylvania, Philadelphia, PA, 1990

Certifications

  • Board Certified, General Surgery

Appointments

  • Member, Board of Directors, American College of Surgeons National Accreditation Program for Breast Centers
  • Chairman, Quality Improvement and Informaton Technology Committee, American College of Surgeons National Accreditation Program for Breast Centers
  • Surveyor, American College of Surgeons National Accreditation Program for Breast Centers
  • Vice Chairman, Society of Surgical Oncology Breast Fellowship Program Directors Training Committee
  • Committee Member, Commission on Cancer Operative Standards Committee
  • Committee Member, Commission on Cancer, Quality Integration Committee

Memberships

  • National Comprehensive Cancer Network (NCCN)
    • Epic User Group Committee
  • American College of Surgeons
  • American College of Surgeons Oncology Group
  • American Medical Informatics Association
  • American Radium Society
  • American Society of Clinical Oncology
  • Association for Academic Surgery
  • Oncology Group American
  • Society of Breast Surgeons
  • International Sentinel Node Society
  • National Comprehensive Cancer Network
  • Radiation Therapy Oncology Group
  • Society of Surgical Oncology
  • Society of University Surgeons 

Honors & Awards

  • Philadelphia Magazine Top Doctors, 2017-20
  • Jamie Brooke Lieberman Remembrance Award, Susan G. Komen® Philadelphia, 2020
  • America's Top Doctors®2016-17
  • Best Doctors in America®, Best Doctors Inc., 2014
  • Breast Cancer Researcher of the Year Award for 2009, Adams County Breast Cancer Coalition
  • Sentinel Node 2002 Congress Young Investigator Award, 2002
  • American Society of Clinical Oncology Merit Award, 2002 

Rosella Nelson

  • Breast Cancer

In 2007, Rosella Nelson was diagnosed with breast cancer after years of being treated for noncancerous fibroids in her right breast. A general surgeon she met with recommended a double mastectomy within a week, which meant removal of both of her breasts and her lymph nodes. Anxious for a second opinion, Rosella scheduled an appointment at Fox Chase Cancer Center, where her surgeon recommended a much less invasive surgery to remove the tumor. Because the surgery was an outpatient procedure, she was able to go home the same day. And because it was Stage 2 cancer and had not metastasized, she did not need any additional treatment. "I can’t say enough about everyone at Fox Chase. There was not one person I met that wasn’t helpful, supportive, and knowledgeable," Rosella said. "I feel very protected in the Fox Chase environment, and I feel that they really care for me and about me. Thanks to Fox Chase, I have both of my breasts and my life to prove it."

VIEW PATIENT STORY

Patti Rose

  • Breast Cancer

At 36, Patti Rose, a wife and mother to seven children, was shocked to learn she had a rare form of breast cancer. Because her husband works in construction and had done several projects for Fox Chase Cancer Center, they knew right away Fox Chase was the right place for Patti's treatment. At Fox Chase, Patti underwent chemotherapy and radiation therapy, followed by a lumpectomy and additional surgery. The experience was extremely difficult, but Patti credits the staff at Fox Chase for giving her a positive outlook and helping her get through it. Today, she is cancer free and could not be more pleased with the treatment she received. "Fox Chase helped me to be positive. If I didn’t have that connection with doctors and nurses and even the security guard that I would talk to every time I was there, I think I would have felt more afraid," she said. "Knowing all those people were praying for me, thinking of me, and trying to get me through it made me feel like I could overcome it."

VIEW PATIENT STORY

Kathleen Marchek

  • Breast Cancer
  • Colorectal Cancer

One cancer diagnosis is bad enough. Two in the same month is really over the top. But that’s exactly what I faced in August 2009 at the age of 54. I was a teacher at the time and was very involved in an afterschool program called Read to Succeed. Our daughter had just graduated from Penn State in May of 2009 and was planning to move home until she found employment.

VIEW PATIENT STORY

Research Interests

Health services research, breast imaging, breast cancer, population studies; Sentinel node biopsy in breast cancer; Novel treatment modalities for breast cancer; Breast cancer clinical trials; Breast imaging and cancer outcomes, Disparities in breast cancer, Male and female breast cancer.

Selected Publications

Bleicher R.J., Moran M.S., Ruth K., Edge S.B., Dietz J.M., Wilke L.G., Stearns V., Kurtzman S.H., Klein J., Yao K.A., The impact of radiotherapy delay in breast conservation patients not receiving chemotherapy and the rationale for dichotomizing the radiation oncology time-dependent standard into two quality measures. Ann Surg Oncol. 29(1): 469-481, 2022.PMC9059503. https://www.ncbi.nlm.nih.gov/pubmed/34324114.

Williams A.D., Chang C., Sigurdson E.R., Wang C.H., Aggon A.A., Hill M.V., Porpiglia A., Bleicher R.J., Neoadjuvant endocrine therapy and delays in surgery for ductal carcinoma in situ: Implications for the coronavirus pandemic. Ann Surg Oncol. 29(3): 1683-1691, 2022.PMC8504964. https://www.ncbi.nlm.nih.gov/pubmed/34635974.

Sharp N.E., Sachs D.B., Melchior N.M., Albaneze P., Nardello S., Sigurdson E.R., Deng M., Aggon A.A., Daly J.M., Bleicher R.J., Does the false-negative rate for 1 or 2 negative sentinel nodes after neo-adjuvant chemotherapy translate into a high local recurrence rate? Breast J. 27(4): 335-344, 2021.PMC8927898. https://www.ncbi.nlm.nih.gov/pubmed/33709448.

Esposito AC, Crawford J, Sigurdson ER, Handorf EA, Hayes SB, Boraas M, Bleicher RJ. Omission of radiotherapy after breast conservation surgery in the postneoadjuvant setting. Journal of Surgical Research, 221:49-57, 2018. PMC5729922

Bleicher RJ, Ruth K, Sigurdson ER, Beck RJ, Ross E, Wong YN, Patel SA, Boraas M, Chang EI, Topham NS, Egleston BL. Time to surgery and breast cancer survival in the United States. In Press, JAMA Oncol 2015

Bleicher RJ, Ruth K, Sigurdson ER, Daly JM, Boraas M, Anderson P, Egleston BL. Breast Conservation Versus Mastectomy for T3 Primaries (>5 cm): A Review of 5,685 Medicare Patients. In Press, Cancer 2015.

Bleicher RJ. Reply to E. Peralta, et al. re: Breast MRI as it is, in contrast to how we wish it to be.  J Clin Oncol 2014; 32, 2818-2819.

Loveland-Jones C, Ruth K, Sigurdson ER, Egleston BL, Boraas M, Bleicher RJ. Breast conservation surgery in the Medicare patient: Will the American College of Surgeons Oncology Group Z0011 Trial change the pattern of care? Br Cancer Res Treat 2014; 143, 571-7. [DOI 10.1007/s10549-014-2834-9, PubMed]

Bleicher RJ, Ruth K, Sigurdson ER, Ross E, Wong YN, Patel SA, Boraas M, Topham NS, Egleston BL. Preoperative delays in the United States Medicare population having breast cancer. J Clin Oncol 2012; 30, 4485-92. [DOI 10.1200/JCO.2012.41.7972, PubMed]

Crivello M, Ruth K, Egleston BL, Sigurdson ER, Wong YN, Boraas M, Bleicher RJ. Advanced imaging modalities in early stage breast cancer– preoperative use in the United States Medicare Patient. Ann Surg Oncol 2013; 20: 102-10. [DOI 10.1245/s10434-012-2571-4, PubMed]

Patel RR, Li T, Ross EA, Sesa L, Sigurdson ER, Bleicher RJ. The effect of simultaneous peripheral excision in breast conservation upon margin status. Ann Surg Oncol 2010; 17, 2933-9. [DOI: 10.1245/s10434-010-1123-z, PubMed, NIHMS: 200283]

Bleicher RJ, Ciocca RM, Egleston BL, Sesa L, Evers K, Sigurdson ER, Morrow M. The association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status. J Am Coll Surg 2009; 209: 180-187. Quiz 294-5. [DOI: 10.1016/j.jamcollsurg.2009.04.010, PubMed

Bleicher RJ, Kloth DD, Robinson D, Axelrod P. Inflammatory cutaneous adverse effects of methylene blue dye injection for lymphatic mapping/sentinel lymphadenectomy. J Surg Oncol 2009; 99:356-60. [DOI: 10.1002/jso.21240, PubMed]

Bleicher RJ, Topham NS, Morrow M. Beauty and the beast: Management of breast cancer after plastic surgery. Ann Surg 2008; 247:680-6. [DOI: 10.1097/SLA.0b013e318161b40f, PubMed]

Additional Publications

116 patient satisfaction reviews

Our Patient Satisfaction Rating is an average of all responses to care provider related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. Learn more.

Overall Rating

4.8 / 5.0

Ratings Breakdown

4.7
Gives easy to understand instruction
4.8
Explains in a way you understand
4.8
Listens carefully to you
4.9
Shows respect for what you say
4.8
Spends enough time with you

15 patient comments

  • 5.0
    March 3, 2022

    Dr. Bleicher & his staff are excellent and I feel safe that they are caring for me.

  • 5.0
    February 21, 2022

    I've only met Dr. Bleicher once so far but it was a very impactful appointment. After just one conversation, he has given me complete confidence that he can help me and REALLY knows his craft. I couldn't be more grateful.

  • 5.0
    November 14, 2021

    I really like my doctor and Fox Chase Center.

  • 5.0
    November 13, 2021

    Very good experience. Very glad I chose Fox Chase and Dr. Bleicher for the care I needed. Everyone was wonderful.

  • 4.5
    October 23, 2021

    Very good visit! Dr. Needs to talk slowly. He was excellent, just needs to slow down

  • 5.0
    August 16, 2021

    Dr. Bleicher was knowledgeable and caring. His staff was courteous and kind.

  • 5.0
    July 29, 2021

    Always a good experience.

  • 5.0
    July 28, 2021

    Very good experience

  • 5.0
    July 28, 2021

    Dr B & his staff are AMAZING!!! He takes his time to fully address & answer my questions, no matter how silly or simple. He is a professional that is relatable. I thank God he was/is my surgeon.

  • 5.0
    July 24, 2021

    I came in for a second opinion/consultation and was extremely impressed with Dr. Bleicher's fellow as well as Dr. Bleicher. I was so impressed I have decided to continue to see Dr. Bleicher for my follow up care/visits.

  • 5.0
    July 24, 2021

    I appreciate Dr. Bleicher and his demeanor which is energetic, focused and intelligent. I feel like he is listening to me as an individual, not just another person with the same diagnosis of breast cancer.The staff are ways kind and professional as well as the interns The imaging staff are wonderful also, truly appreciated as the women who are waiting are anxious, and appreciate hearing kind words.

  • 5.0
    June 14, 2021

    Everyone on my team including Dr. Bleicher and staff are all knowledgeable, kind and caring. Thankful I was treated at Fox Chase.

  • 5.0
    April 27, 2021

    First-rate experience.

  • 5.0
    January 24, 2021

    Dr Bleicher was very optimistic and comforting. I feel confident that I can get through my Cancer treatments with a good outcome.

  • 5.0
    December 23, 2020

    I always feel reassured, knowing Dr. Bleicher is doing the best for me.